abstract |
It relates to a composition for enhancing the susceptibility of prostate cancer to an anticancer agent, which can overcome the resistance of cancer cells to a target anticancer agent, and can increase the sensitivity of the anticancer agent to cancer cells, as well as use it in combination with a conventional target anticancer agent. By administration, the therapeutic effect of prostate cancer can be improved. |